Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Half Yearly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 16:00
2652.65
-63.2 (-2.33%)
VOLUME 2,356
LIVE
NSE
Dec 06, 15:57
2652.10
-65.75 (-2.42%)
VOLUME 30,818
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Half Yearly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Sep '19 Mar '19 Sep '18 Mar '18 Sep '17
Net Sales/Income from operations 413.04 405.50 322.80 279.27 291.74
Other Operating Income -- -- -- -- --
Total Income From Operations 413.04 405.50 322.80 279.27 291.74
EXPENDITURE
Consumption of Raw Materials 32.04 39.08 26.34 19.28 8.60
Purchase of Traded Goods 110.26 122.48 47.36 97.99 106.22
Increase/Decrease in Stocks 1.90 -33.77 32.38 -34.77 -16.22
Power & Fuel -- -- -- -- --
Employees Cost 102.90 112.52 88.02 82.19 71.34
Depreciation 9.27 7.69 7.22 7.28 7.46
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 31.00 39.50 40.30 45.68 27.12
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 65.84 78.44 64.35 64.47 52.81
P/L Before Other Inc. , Int., Excpt. Items & Tax 59.85 39.56 16.82 -2.86 34.41
Other Income 6.15 9.51 6.78 5.10 7.15
P/L Before Int., Excpt. Items & Tax 66.00 49.07 23.60 2.24 41.56
Interest 0.58 -- -- -- --
P/L Before Exceptional Items & Tax 65.43 49.07 23.60 2.24 41.56
Exceptional Items -- -- -- -- --
P/L Before Tax 65.43 49.07 23.60 2.24 41.56
Tax 29.49 10.15 8.07 9.37 8.38
P/L After Tax from Ordinary Activities 35.93 38.92 15.53 -7.13 33.18
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 35.93 38.92 15.53 -7.13 33.18
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 14.37 -- 6.21 -- 13.27
Diluted EPS 14.37 -- 6.21 -- 13.27
EPS After Extra Ordinary
Basic EPS 14.37 -- 6.21 -- 13.27
Diluted EPS 14.37 -- 6.21 -- 13.27
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of AstraZeneca

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.